title: Marginal iodide deficiency and thyroid function: dose-response analysis for quantitative pharmacokinetic modeling.
abstract: Severe iodine deficiency (ID) results in adverse health outcomes and remains a benchmark for understanding the effects of developmental hypothyroidism. The implications of marginal ID, however, remain less well known. The current study examined the relationship between graded levels of ID in rats and serum thyroid hormones, thyroid iodine content, and urinary iodide excretion. The goals of this study were to provide parametric and dose-response information for development of a quantitative model of the thyroid axis. Female Long Evans rats were fed casein-based diets containing varying iodine (I) concentrations for 8 weeks. Diets were created by adding 975, 200, 125, 25, or 0 μg/kg I to the base diet (~25 μg I/kg chow) to produce 5 nominal I levels, ranging from excess (basal+added I, Treatment 1: 1000 μg I/kg chow) to deficient (Treatment 5: 25 μg I/kg chow). Food intake and body weight were monitored throughout and on 2 consecutive days each week over the 8-week exposure period, animals were placed in metabolism cages to capture urine. Food, water intake, and body weight gain did not differ among treatment groups. Serum T4 was dose-dependently reduced relative to Treatment 1 with significant declines (19 and 48%) at the two lowest I groups, and no significant changes in serum T3 or TSH were detected. Increases in thyroid weight and decreases in thyroidal and urinary iodide content were observed as a function of decreasing I in the diet. Data were compared with predictions from a recently published biologically based dose-response (BBDR) model for ID. Relative to model predictions, female Long Evans rats under the conditions of this study appeared more resilient to low I intake. These results challenge existing models and provide essential information for development of quantitative BBDR models for ID during pregnancy and lactation.
authors.affiliation: Toxicity Assessment Division (MD-B105-05), National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, 109 TW Alexander Drive, Research Triangle Park, NC 27711, USA. gilbert.mary@epa.gov
authors.forename: M E
authors.initials: ME
authors.lastname: Gilbert
authors.forename: E D
authors.initials: ED
authors.lastname: McLanahan
authors.forename: J
authors.initials: J
authors.lastname: Hedge
authors.forename: K M
authors.initials: KM
authors.lastname: Crofton
authors.forename: J W
authors.initials: JW
authors.lastname: Fisher
authors.forename: L
authors.initials: L
authors.lastname: Valentín-Blasini
authors.forename: B C
authors.initials: BC
authors.lastname: Blount
mesh_terms: D000818:Animals; D001835:Body Weight / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000502:physiology; D005260:Female; D007455:Iodine / Q000008:administration & dosage / Q000172:deficiency* / Q000493:pharmacokinetics / Q000652:urine; D023421:Models, Animal; D008954:Models, Biological; D009929:Organ Size / Q000502:physiology; D051381:Rats; D020318:Rats, Long-Evans; D013961:Thyroid Gland / Q000737:chemistry / Q000378:metabolism*; D013972:Thyrotropin / Q000097:blood / Q000378:metabolism*; D013974:Thyroxine / Q000097:blood / Q000378:metabolism*; D014284:Triiodothyronine / Q000097:blood / Q000378:metabolism*
chemical_list: D014284:Triiodothyronine; D013972:Thyrotropin; D007455:Iodine; D013974:Thyroxine